chr1-946207-C-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015658.4(NOC2L):c.1883G>A(p.Arg628Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000248 in 1,613,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015658.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| NOC2L | ENST00000327044.7 | c.1883G>A | p.Arg628Gln | missense_variant | Exon 16 of 19 | 1 | NM_015658.4 | ENSP00000317992.6 | ||
| NOC2L | ENST00000477976.5 | n.3330G>A | non_coding_transcript_exon_variant | Exon 14 of 17 | 5 | |||||
| NOC2L | ENST00000483767.5 | n.739G>A | non_coding_transcript_exon_variant | Exon 2 of 5 | 2 | 
Frequencies
GnomAD3 genomes  0.000250  AC: 38AN: 152244Hom.:  0  Cov.: 34 show subpopulations 
GnomAD2 exomes  AF:  0.000200  AC: 50AN: 250622 AF XY:  0.000221   show subpopulations 
GnomAD4 exome  AF:  0.000248  AC: 362AN: 1460952Hom.:  0  Cov.: 30 AF XY:  0.000227  AC XY: 165AN XY: 726652 show subpopulations 
Age Distribution
GnomAD4 genome  0.000249  AC: 38AN: 152362Hom.:  0  Cov.: 34 AF XY:  0.000309  AC XY: 23AN XY: 74506 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The c.1883G>A (p.R628Q) alteration is located in exon 16 (coding exon 16) of the NOC2L gene. This alteration results from a G to A substitution at nucleotide position 1883, causing the arginine (R) at amino acid position 628 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at